| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Friday - Oct 11, 2024 |
|||||||||
| Q3 FY24 | $4.37 | $3.99 | $42.66B | $41.43B |
NYSE |
||||
| Q3 FY24 | $1.52 | $1.28 | $20.37B | $20.40B |
NYSE |
||||
| Q3 FY24 | $11.46 | $10.33 | $5.20B | $5.03B |
NYSE |
||||
| Q3 FY24 | $1.52 | $1.42 | $4.56B | $4.54B |
NYSE |
||||
| Q3 FY24 | $0.26 | $0.51 | $1.91B | $1.90B |
NASDAQ |
||||
|
Bank7
BSVN
|
Q3 FY24 | $1.24 | $1.07 | $24.89M | $23.50M |
NASDAQ |
|||
|
Hingham Institution for Savings
HIFS
|
- | $1.44 | - | $15.21M | - |
NASDAQ |
|||
|
CeriBell
CBLL
|
- | -$1.59 | - | $14.86M | - |
NASDAQ |
|||
|
Nurix Therapeutics
NRIX
|
- | -$0.67 | -$0.67 | $12.59M | $12.81M |
NASDAQ |
|||
|
SCWorx
WORX
|
- | -$0.26 | - | $742.03K | - |
NASDAQ |
|||
